Newer oral anticoagulants: A review of laboratory monitoring options and reversal agents in the hemorrhagic patient
American Journal of Health-System Pharmacy, 08/21/2012
Clinical Article
Miyares MA et al. – Although there is currently no gold standard of measurement for any of the newer anticoagulants, the published literature enables practitioners to evaluate the efficacy and sensitivity of a majority of these assays. Prohemostatic agents can be used in instances of severe, life–threatening hemorrhagic complications.



